Загрузка...
A rare case of imatinib-induced erythroderma
Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe a...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3847261/ https://ncbi.nlm.nih.gov/pubmed/24347779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.121386 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|